Stimulation of cyclic GMP formation in smooth muscle cells by atriopeptin II.

doi:10.1016/0024-3205(85)90425-4

Life Sciences

Volume 37, Issue 7, 19 August 1985, Pages 591-597

https://doi.org/10.1016/0024-3205(85)90425-4 Get rights and content

Abstract

Addition of synthesized atriopeptin II (AP-2), a 23 amino acid peptide of rat atria, to rat thoracic aorta smooth muscle cells results in the stimulation of cyclic GMP production by the cells. The EC₅₀ for the effect is 81 nM and a 7 fold increase occurs at 10 μM AP-2. Cyclic GMP levels increased within 15 seconds after the addition of AP-2 and were maximal at 5 minutes. Cyclic GMP levels in primary rabbit kidney cells were increased 15 fold by 10 μM AP-2. However, no increase in cyclic GMP was detected in WI-38 fibroblast cells after the addition of 10 μM AP-2. Cyclic AMP levels were not affected by AP-2 in any of these cell systems. The effect upon cyclic GMP accumulation was specific for AP-2; none of the other compounds or peptides tested affected cyclic GMP levels.

References (36)

A.J. De Bold et al.
Life Sci.
(1981)
T.G. Flynn et al.
Biochem. Biophys. Res. Commun.
(1983)
K. Kangawa et al.
Biochem. Biophys. Res. Commun.
(1984)
D.M. Geller et al.
Biochem. Biophys. Res. Commun.
(1984)
G. Thibault et al.
FEBS Letters
(1983)
K.S. Misono et al.
Biochem. Biophys. Res. Commun.
(1984)
K. Kangawa et al.
Biochem. Biophys. Res. Commun.
(1984)
R.T. Grammer et al.
Biochem. Biophys. Res. Commun.
(1983)
R. Garcia et al.
Biochem. Biophys. Res. Commun.
(1984)
B.W. Kimes et al.
Exptl. Cell Res.
(1976)

E. Kaiser et al.

Anal. Biochem.

(1970)

G.L. Ellman

Arch. Biochem. Biophys.

(1959)

P. Hamet et al.

Biochem. Biophys. Res. Commun.

(1984)

M.G. Currie et al.

Science

(1984)

N.G. Seidah et al.

M.G. Currie et al.

Science

(1983)

S. Katsuki et al.

Mol. Pharmacol.

(1977)

E. Bohme et al.

Adv. Cyclic Nucleotide Res.

(1978)

Cited by (15)

Different time course of atrial natriuretic factor-induced relaxation in rabbit aorta and portal vein
1990, European Journal of Pharmacology
Atrial natriuretic factor (ANF) and nitroglycerine were tested in superfused rabbit aorta and portal vein strips precontracted with norepinephrine. The ANF dose-response curves were similar in both tissues, however, relaxation was fast and transient in portal veins whereas it was sustained and of slow onset in aortas. Nitroglycerine was more potent in portal veins than in aortas but relaxation was fast and transient in both tissues. The results suggest that the time course of ANF-induced relaxation in different vessels may be of relevance to the overall hemodynamic profile of this peptide in intact animals.
Effect of atriopeptin II on Ca influx, contractile behavior and cyclic nucleotide content of cultured neonatal rat myocardial cells
1990, Journal of Molecular and Cellular Cardiology
The present study was carried out to evaluate the effects of biologically active atriopeptin II (APII) in synchronously contracting monolayer cultures of rat ventricular myocytes. The effects of 10 nm APII on Ca influx, contractile behavior and cyclic nucleotide content of the cells were measured. Applied acutely APII had no effect on Ca influx. There was however a time-dependent effect such that after 30 min Ca influx (pmol/cm²/s) had declined from a control (mean ± s.e.m.) of 1.53 ± 0.16 to 1.02 ± 0.07 (P<0.001; n = 6). There was parallel decline in both the magnitude and velocity of cell edge motion which was maximal in 30 min at which time cell edge motion measured 65.3 ± 4.4% of control. Treatment with APII for 30 min decreased cAMP (pmol/mg protein) from 5.35 ± 0.17 to 2.86 ± 0.24 (P<0.001; n = 5). At the same time cGMP (pmol/mg protein) increased from 0.86 ± 0.21 to 2.21 ± 0.33 (P<0.001; n = 5). Further studies elucidated the fact that the decline in Ca influx and contractile behavior was dependent on the decrease in cAMP rather than the increase in cGMP. Pre-treatment of the cells with 5 ng/ml of pertussis toxin to ADP-ribosylate the G_i protein abolished the effects of APII on cAMP, Ca influx and contractile behavior. The results indicate that in myocardial cells, as in other cells, APII stimulates guanylate cyclase and inhibits adenylate cyclase. The resultant fall in cAMP decreases Ca influx and negatively influences the contractile behavior of the cells.
Sustained dilatation of large coronary artery by α-human atrial natriuretic peptide in conscious dogs: a comparison with nitroglycerin
1989, European Journal of Pharmacology
The effects of α-human atrial natriuretic peptide (α-hANP) on the coronary circulation were compared with those of nitroglycerin in 16 conscious dogs chronically instrumented with a pair of miniature sonomicrometers and an electromagnetic flow probe placed on the left cirumflex coronary artery. α-hANP (1 and 10 ωg) and nitroglycerin (0.1, 1 and 10 ωg) were administered intracoronarily via a cannula implanted in the proximal left circumflex coronary artery. Both α-hANP and nitroglyce Although α-hANP (10 ωg) and nitroglycerin (1 ωg) dilated the large coronary artery to almost the same extent (92 ± 10 vs 98 ± 8 μm), the time course of the dilating action differed; the peak dilatation occurred at 5.6 ± 0.8 and 0.9 ± 0.07 min (P < 0.01), and full recovery occurred at 31.5 ± 3.8 and 5.5 ± 1.3 min (P < 0.01) after α-hANP and nitroglycerin, respectively. Topical application of α-hANP (50 ωg) to the epicardial coronary artery of three anesthetized open-chest dogs did not affect the coronary diameter and coronary blood flow, while nitroglycerin (50 ωg) increased both variables. Thus, intracoronary α-hANP dilates the large coronary artery more gradually and more sustainedly than nitroglycerin does.
Cyclic nucleotides depress action potentials in cultured aortic smooth muscle cells
1987, European Journal of Pharmacology
The effects of cyclic nucleotide analogs and related agents on the Ca²⁺ dependent action potentials of cultured rat aortic smooth muscle cells (reaggregates) were examined. The action potentials were elicited by electrical stimulation in the presence of tetraethylammonium (TEA, 5–15 mM). Superfusion of the aortic cells with analogs of cyclic AMP (dibutyryl or 8-bromo-cyclic AMP, 1 mM), isoproterenol (1–10 μM) and forskolin (1–10 μm) depressed and abolished the TEA-induced action potentials. Abolition of the action potentials by these agents was reversible and was accompanied by some hyperpolarization of the membrane. Superfusion with 8-bromo-cyclic GMP (0.1–1 mM) also depressed or abolished the TEA-induced action potentials, whereas dibutyryl cyclic GMP (1 mM) and sodium nitroprusside (10 μM) had little effect. Synthetic atrial natriuretic factor (0.01–0.1 μM) had inhibitory effects in most experiments. Thus, depression of membrane excitability may be a contributing factor in the relaxation of aortic smooth muscle produced by some agents that increase intracellular levels of cyclic nucleotides.
Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: Evidence for receptor subtypes
1987, Biochemical and Biophysical Research Communications
ANF analog potencies in stimulating smooth muscle cell cGMP were compared with the ability to relax histamine-constricted rabbit aorta in vitro. ANF[1–28]³, [5–28], [5–27] and Lys-11[5–28] elevated cGMP and were potent vasorelaxants. ANF[7–23] and Lys-11[7–23] were potent cGMP stimulators but 1000-fold weaker relaxants. Tyr-8[5–27] did not stimulate cGMP synthesis or antagonize the response of the other peptides, yet was a potent vasorelaxant. Crosslinking with ¹²⁵I-ANF identified bands at 150 and 65 KD by SDS-PAGE. ANF[1–28], Lys-11[7–23] and Tyr-8[5–27] blocked crosslinking at low-concentration despite disparate activities. These data support the existence of ANF receptor subtypes and suggest that cGMP elevation alone is not sufficient to promote atrial peptide-induced vasorelaxation.
Hormonal signals and intracellular messengers for renin secretion
1986, Molecular and Cellular Endocrinology

View all citing articles on Scopus

View full text

Stimulation of cyclic GMP formation in smooth muscle cells by atriopeptin II.

Abstract

Life Sci.

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

FEBS Letters

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

Biochem. Biophys. Res. Commun.

Exptl. Cell Res.

Anal. Biochem.

Arch. Biochem. Biophys.

Biochem. Biophys. Res. Commun.

Science

Science

Mol. Pharmacol.

Adv. Cyclic Nucleotide Res.